ReWalk Robotics (NASDAQ:RWLK) Receives New Coverage from Analysts at began coverage on shares of ReWalk Robotics (NASDAQ:RWLKGet Rating) in a research report sent to investors on Monday. The firm issued a sell rating on the medical device company’s stock.

Separately, HC Wainwright reaffirmed a buy rating and issued a $3.00 price target on shares of ReWalk Robotics in a research report on Friday, February 24th.

ReWalk Robotics Price Performance

Shares of ReWalk Robotics stock opened at $0.61 on Monday. The business has a 50-day moving average of $0.65 and a 200 day moving average of $0.76. ReWalk Robotics has a 12 month low of $0.56 and a 12 month high of $1.14. The stock has a market capitalization of $36.10 million, a price-to-earnings ratio of -1.89 and a beta of 2.46.

ReWalk Robotics (NASDAQ:RWLKGet Rating) last posted its quarterly earnings results on Thursday, February 23rd. The medical device company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). The company had revenue of $2.18 million during the quarter, compared to analyst estimates of $2.10 million. ReWalk Robotics had a negative net margin of 333.16% and a negative return on equity of 27.12%. Equities research analysts anticipate that ReWalk Robotics will post -0.29 earnings per share for the current year.

Insiders Place Their Bets

In other news, major shareholder Global Fund Lp Lind II purchased 102,098 shares of the business’s stock in a transaction on Monday, March 6th. The shares were bought at an average price of $0.79 per share, with a total value of $80,657.42. Following the completion of the transaction, the insider now directly owns 4,963,633 shares in the company, valued at approximately $3,921,270.07. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.78% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Renaissance Technologies LLC increased its holdings in shares of ReWalk Robotics by 23.0% in the first quarter. Renaissance Technologies LLC now owns 180,500 shares of the medical device company’s stock valued at $130,000 after purchasing an additional 33,700 shares during the period. Virtu Financial LLC grew its holdings in ReWalk Robotics by 249.6% during the fourth quarter. Virtu Financial LLC now owns 47,638 shares of the medical device company’s stock worth $36,000 after acquiring an additional 34,013 shares during the period. Finally, Millennium Management LLC grew its holdings in ReWalk Robotics by 42.9% during the fourth quarter. Millennium Management LLC now owns 139,009 shares of the medical device company’s stock worth $106,000 after acquiring an additional 41,753 shares during the period. Institutional investors and hedge funds own 4.44% of the company’s stock.

ReWalk Robotics Company Profile

(Get Rating)

ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm’s exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs.

Featured Articles

Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with's FREE daily email newsletter.